Skip to main content
logo
Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan flag Japan · Delayed Price · Currency is JPY
3,495.00
-75.00 (-2.10%)
Oct 2, 2026, 3:30 PM JST

Towa Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
172,051197,158131,879142,93393,275135,736
Market Cap Growth
19.69%49.50%-7.73%53.24%-31.28%12.90%
Enterprise Value
359,749390,997326,106308,406222,967195,152
Last Close Price
3495.003961.532589.752740.551752.112465.51

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
20.8137.556.958.8442.388.53
Forward PE
7.459.788.3711.9911.968.06
PS Ratio
0.610.720.510.630.450.82
PB Ratio
0.941.110.770.920.681.03
P/TBV Ratio
1.101.301.051.361.111.74
P/FCF Ratio
40.1624.19---12.35
P/OCF Ratio
6.816.485.6417.4136.676.13
PEG Ratio
0.115.585.585.585.587.28

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
1.291.431.261.351.071.18
EV/EBITDA Ratio
7.648.517.528.688.956.62
EV/EBIT Ratio
14.7316.9214.0317.4840.4310.53
EV/FCF Ratio
83.9847.96---17.76

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
1.261.291.381.321.261.09
Debt / EBITDA Ratio
4.894.985.455.806.944.89
Debt / FCF Ratio
53.6728.09---13.12
Net Debt / Equity Ratio
1.031.031.111.131.090.84
Net Debt / EBITDA Ratio
3.994.004.404.975.973.77
Net Debt / FCF Ratio
43.8122.53-35.78-5.96-5.6810.13
Asset Turnover
0.590.580.580.570.600.57
Inventory Turnover
1.481.511.581.511.641.43
Quick Ratio
1.201.231.331.261.000.73
Current Ratio
2.822.762.812.722.331.45
Return on Equity (ROE)
-3.00%11.59%11.05%1.64%12.79%
Return on Assets (ROA)
-3.05%3.22%2.75%0.98%4.03%
Return on Invested Capital (ROIC)
3.22%2.54%4.82%3.78%1.00%6.29%
Return on Capital Employed (ROCE)
6.40%6.10%6.10%5.00%1.90%8.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
4.81%2.66%14.40%11.31%2.36%11.72%
FCF Yield
2.49%4.13%-4.04%-20.74%-28.07%8.10%
Dividend Yield
2.43%2.02%2.70%2.19%3.42%2.31%
Payout Ratio
47.73%74.99%15.55%18.25%140.84%15.15%
Buyback Yield / Dilution
-0.00%-0.01%-0.01%0.00%2.19%1.86%
Total Shareholder Return
2.43%2.01%2.69%2.19%5.62%4.17%